NRX Pharmaceuticals shares are trading lower after the company announced a $6.28 million registered direct offering.
Portfolio Pulse from Benzinga Newsdesk
NRX Pharmaceuticals announced a $6.28 million registered direct offering, causing its shares to trade lower.
June 06, 2023 | 7:51 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
NRX Pharmaceuticals' stock price is trading lower due to the announcement of a $6.28 million registered direct offering.
NRX Pharmaceuticals announced a $6.28 million registered direct offering, which typically leads to stock dilution and a decrease in share price. As a result, the stock price is trading lower.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100